CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

This publication has 12 references indexed in Scilit:

• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Congestive heart failure after acute myocardial infarction in patients receiving antiarrhythmic agents for ventricular premature complexes (Cardiac Arrhythmia Pilot Study)
  The American Journal of Cardiology, 1989
• Clinical Characteristics of Patients with Ventricular Fibrillation during Antiarrhythmic Drug Therapy
  New England Journal of Medicine, 1988
• Direct and autonomically mediated effects of oral flecainide
  The American Journal of Cardiology, 1988
• The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity
  American Heart Journal, 1985
• Effect of antiarrhythmic drugs on mortality after myocardial infarction
  The American Journal of Cardiology, 1983
• Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide
  Cardiovascular Research, 1983
• Drug conversion of nonsustained ventricular tachycardia to sustained ventricular tachycardia during serial electrophysiologic studies: Identification of drugs that exacerbate tachycardia and potential mechanisms
  American Heart Journal, 1982
• Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs
  The American Journal of Cardiology, 1977